Загрузка...
Case Report: Haemolytic anaemia with ceftazidime use in a patient with cystic fibrosis
Drug-induced Immune Haemolytic Anaemia (DIIHA) is a rare but serious complication of cephalosporin use. Ceftazidime is recognized to be a rare cause of DIIHA. We report and discuss a case of DIIHA in a person with cystic fibrosis who developed severe haemolytic anaemia following use of ceftazidime i...
Сохранить в:
| Опубликовано в: : | F1000Res |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
F1000 Research Limited
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5920311/ https://ncbi.nlm.nih.gov/pubmed/29770214 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.14505.1 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|